AlbuquerqueP. F., De TurnaM.: Investigations on urolithiasis. - II. Studies on oxalate. J. Urol., 87; 504 (1962).
2.
AndersonD. A.: Historical and geographical differences in the pattern of incidence of urinary stones considered in relation to possible aetiological factors. in: Renal Stone Research Symposium, pag. 7, J. & A. Churchill Ltd., London.
3.
ArcherH. E., DormerA. E., ScovenE. F., WaltsR. W. E.: Studies on the urinary excretion of oxalate by normal subjects. Clin. Sci., 16; 405 (1957).
4.
BeckC. W., MulvaneyW. P.: Apatitic urinary calculi from early American Indians. J.A.M.A., 195; 1044 (1966).
BernsteinD. S., NewtonR.: The effects of oral sodium phosphate on the formation of renal calculi and on idiopatic hypercalciuria. Lancet, 11; 1105 (1966).
7.
BlacklockN. J.: The pattern of urolithiasis.in: Renal Stone Research Symposium.J. & A. Churchill Ltd., London.
8.
BordenT. A., LyonE. S.: The effects of magnesium and pH on experimental calcium oxalate stone disease. Invest. Urol., 6; 412 (1969).
9.
BorgnoM., Marten PerolinoR.: Aspetti chimici e cristallografici delle calcolosi di ossalati di calcio. Minerva urol., 14; 1 (1962).
10.
BorgnoM., Marten PerolinoR.: Cenni di etiopatogenesi ed attuali orientamenti nella terapia medica della litiasi renale. Minerva Med., 60; 1543 (1969).
11.
BoyceW. H., GarveyF. K., StrawcutterH. E.: Incidence of urinary calculi among patients in general Hospitals. J.A.M.A., 161; 1433 (1956).
12.
BoyceH. W., KingI. S.Jr.: Cristal matrix interrelations in calculi. J. Urol., 81; 351 (1959).
13.
BoyceW. H., BradshawH. H.: Differentiation of Hyperparathyroidism and other disease associated with recurrent urinary calculi: A clinical evaluation of some currently available laboratory methods. Trans. Amer. Ass. Genito-Urinary Surg., 52; 11 (1960).
14.
BoyceW. H.: The renal tubule in the genesis of renal calculi. Proc. 3rd Int. Congr. Nephrol., vol. 2, pag. 354, Washington 1966.
15.
BoyceW. H.: Organix matrix of human urinary concretions. Am. J. Med., 45; 673 (1968).
16.
BoyceW. H.: Macromolecolar components of kidney calculi in urine. in: Renal Stone Research Symposium, pag. 181, J. & A. Churchill Ltd., London1969.
17.
BurchP. R. J., DawsonJ. B.: Aetiological implications of the sex and age-distribution of renal lithiasis. in: Renal Stone Research Symposium.J. & A. Churchill Ltd., London1969.
18.
ButtA. J.: Etiologic factors in renal lithiasis. Thomas Ed., pag. 401, Springfield 1956.
19.
CampanacciD., BonominiV.: Significato e limiti delle varie metodiche per la diagnosi delle pielonefriti. Minerva Nefrol., 10; 67 (1963).
20.
CarrR. J.: Aetiology of renal calculi: Micro-radiographic studies. in: Renal Stone Research Symposium, pag. 123. J. & A. Churchill Ltd., London1969
21.
CattaneoC., MartiniP. F., ModicaA.: The maximum tubular reabsorption of phosphate in acromegaly. Acta Endocr., 45; 203 (1964).
22.
ChambersR. M., DormondyT. L.: Measurement and interpretation of hypercalciuria on twenty four-hour urine series. Lancet, 7531; 1378 (1967).
23.
ChambersR. M., DormondyT. L.: Hypercalciuria relative and absolute. in: Renal Stone Research Symposium, pag. 233. J. A. Churchill Ltd., London1969.
24.
CharltonC. A. C.: The relation of urolithiasis to urinary fibrinolytic activity. In: Renal Stone Research, etc., pag. 191.
25.
CharltonC. A. C.: Fibrinolysis and urolithiasis. Lancet, 1; 1199 (1967).
26.
ClarksonE. M., WarrenR. L., Mc DonaldS. J., De WardenerH. E.: The effect of a high intake of calcium on magnesium metabolism in normal subjects and patients with chronic renal failure. Clin. Sci., 32; 11 (1967).
27.
CrawhallJ. C., WattsR. W. E.: The oxalate content of human plasma. Clin. Sci., 20; 357 (1961).
28.
CoeF. L.: A diagnostic approach to the patient with renal stones. Medical Times, 98; 87 (1970).
29.
CorradoF., ZucchelliP., FusaroliM., MaverA.: Il bilancio elettrolitico nella calcolosi radiopaca. Atti 42° Congr. Soc. it. Urol., Merano 6–10 ottobre 1969.
30.
CottetJ., VittuC., LemahienJ. C.: Oxalurie et lithiase urinaires. J. d'Urol., 71; 70 (1965).
31.
CottetJ., VittuC., LemahienJ. C.: Interesse dell'ossaluria nella genesi e nella dietetica della litiasi ossalica. Clin. Terap., 44; 3 (1968).
DentC. E., WatsonL.: Metabolic studies in a patient with idiopathic hypercalciuria. Brit. med. J., 2; 449 (1965).
36.
DesgrezP., ThomasJ., David IssartelR.: Oxaluria, forme hyperoxalurique, non familiale de la lithiase oxalique. J. d'Urol., 74; 685 (1968).
37.
EttingerR. H., GoldbaumL. R., SmithL. H.Jr.: A simplified photometric method for the determination of citric acid in biological fluid. J. Biolchem., 199; 531 (1952).
38.
EuschioE., ElliotJ. S.: Effects of trace metals on the crystallization of calcium oxalate. Invest. Urol., 4; 431 (1967).
39.
EvansR. A., ForbesM., SuttonRal, WatsonL.: Urinary excretion of calcium and magnesium in patients with calcium containing renal stones. Lancet, 11; 958 (1967).
40.
FaberS. R., FeitlerW. W., BleiberR. E., OhlsonM. A., HodgesR. E.: The effects of an induced pyrodoxine and pantothenic acid deficiency on excretion of oxalic and xanthurenic acids in the urine. Amer. J. Clin. Nutr., 12; 406 (1963).
41.
FidalgoB., ChordiA.: Urinary alfa2-mucoprotein in patients with renal lithiasis. Lancet, 1; 235 (1965).
42.
FleischH., BisazS., CareA. D.: Effect of orthophosphate on urinary pyrophosphate excretion and the prevention of urolithiasis. Lancet, 1; 1065 (1964).
43.
FleischH., BisazS., RusselR. G. C.: Influence of pyrophosphate on the crystallisation of uric acid and magnesium phosphate and its implications in phosphate therapy for urolithiasis. Urol. Intern., 22; 483 (1967).
44.
FlocksR. H.: Calcium and phosphate excretion in the urine of patients with renal and ureteral calculi. J.A.M.A., 113; 1466 (1939).
45.
FriesD., TraegerJ., FrancoisB., PelletM., RevillardA.: À propos d'une observation d'oxalose. J. d'Urol., 69; 647 (1963).
46.
GalleP.: Nouvelle méthode d'analyse des incrustations minérales du rein. Acta Néphrol. Hôp. Necker, pag. 193(1965).
47.
GastaldiL., BucciantiG., RizzatoG., MarazziniL.: Alcuni aspetti del metabolismo renale dell'ac. urico. Minerva med., 61; 3595 (1970).
48.
GershbergH., MariS., St. PaulH.: The one hour responce to parathyroid extract in hyperparathyroidism and renal disease. Metabolism, If; 206 (1966).
49.
GershoffS. N., FaragallaF. F.: Endogenous oxalate synthesis and glicine, serine-deoxypyridoxine interrelationship in vit. B6 deficient rats. J. Biol. Chem., 234; 2391 (1959).
50.
GershoffS. N., PrienE. L.: Effects of daily MgO and vitamin B6 administration to patients with recurring calcium oxalate kidney stones. Amer J. Clin. Nutr., 20; 393 (1967).
51.
GreenwaldI., RedishJ., KibrickA. C.: The dissociation of calcium and magnesium phosphate. J. Biol. Chem., 135; 65 (1940).
52.
GyöryA. Z., EdwardK. D. G., RobinsonJ., PalmerA. A.: The relative importance of urinary pH and urinary content of citrate, magnesium and calcium in the production of nephrocalcinosis by diet and acetozolamide in the rat. Clin. Sci., 39; 605 (1970).
HerringL. C.: Observations in the analysis of ten thousand urinary calculi. J. Urol., 88; 545 (1962).
55.
HigginsC. C.: Experimental production of urinary calculi in rats. Lancet, 53; 522 (1933).
56.
HockadayT. D. R., FrederickE. W., ClaytonJ. E., SmithL. H.Jr.: Studies on primary hyperoxaluria. II. Urinary oxalate, glycolate and glyoxylate measurement by isotope dilution method. J. Lab. Clin. Med., 65; 677 (1965).
57.
HockadayT. D. R., ClaytonJ. E., FrederickE. W., SmithL. H.Jr.: Primary hyperoxaluria. Medecine, 43; 315 (1964).
58.
HodgkinsonA., PyrahL. N.: The urinary excretion of calcium and inorganic phosphate in 344 patients with calcium stone of renal origin. Brit. J. Sur., 46; 10 (1958).
59.
HodgkinsonA.: Citric acid excretion in ormai adults and in patients with renal calculus. Clin. Sci., 23; 203 (1962).
HodgkinsonA., PeacockM., NicholsonM.: Quantitative analysis of calcium containing urinary calculi. in: Renal Stone Research Symposium, pag. 113, J. & A. Churchill Ltd., London1969.
62.
HollerbergH., Sandberg: Tubular reabsorption of phosphate in nephrolithiasis and hyperparathiroidism. Scand. J. Urol. Nephrol., 2; 109 (1968).
63.
HowardJ. E., HopkinsT. R., ConnorT. B.: Use of intravenous calcium as a mesure of activity of the parathyroid gland. Trans. Ass. Amer. Phys., 65; 351 (1952).
64.
HowardJ. E., HopkinsT. R., ConnorT. B.: On certain physiologic responses to intravenous injection of calcium salts into normal, hyperparathyroid and hypoparathyroid persons. J. Clin. Endocr., 13; 1 (1953).
KyleL. H., CanaryJ. J., MintzD. H., De LeonA.: Inhibitory effects of induced hypercalcemia on secretion of parathyroid hormone. J. Clin. Invest., 22; 52 (1962).
72.
KyleL. H., BeiselW. R., CanaryJ. J.: Evaluation of the relative value of diagnostic test in hyperparathyroidism. Ann. Intern. Med., 57; 957 (1962).
73.
KlugH. P., AlexanderL. E.: X-Ray diffraction procedures.Wiley & Sons Inc., New York1959.
74.
KnyW., MajxencarD.: Citrate elimination and urinary calculus formation. Z. Urol., Nephrol., 58; 243 (1965).
75.
LaersumV. E. C.: Vitamin A deficiency and calcification of epitelium of kidney. J. Biol. Chem., 79; 461 (1928).
76.
LewisG. N., RandallM.: Thermodynamics and the free energy of chemical substances.MacGraw - Hill Book Company, New York1923.
77.
LievreA., CamusJ. P., BriffodP. H.: Le metabolism phosphocalcique dans l'hyperparathyroidism. Presse méd., 75; 5 (1967).
78.
LemanJr., PieringW. F., LennonE. J.: Possible role of carbohydrate. Induced calciuria in calcium oxalate kidney stone formation. N. Engl. J. Med., 280; 232 (1969).
79.
LifshitzF., HarrisonH. C., BullE. C., HarrisonH. E.: Citrate metabolism and the mechanism of renal calcification induced by magnesium depletion. Metabolism, 16; 345 (1967).
80.
LitchwitzA., ParlierR., SezeS., HiocoD., MiravelL.: L'effet hypocalciurique des sulfamides diurétiques. Sem. Hôp. Paris, 37; 2350 (1961).
81.
LyonE. S., BordenT. A., EllisJ. E., VermeulenC. W.: Calcium oxalate lithiasis produced by pyridoxine deficiency and inhibition with high magnesium diets. Invest. Urol., 4; 133 (1966).
82.
LyonE. S., BordenT. A., EllisJ. E., VermeulenC. W.: Experimental oxalate lithiasis produced with ethylene glycol. Invest. Urol., 4; 143 (1966).
83.
MatesJ.: External factors in the genesis of urolithiasis. in: Renal Stone Research Symposium, pag. 59. J. & A. Churchill Ltd., London1969.
84.
MatteucciE.: Limite di reperibilità diffrattometrica. Rendiconti della Soc. it. Mineralogia e Petrologia, 24; 1 (1968).
85.
MayerJ.: Nutrition and renal calculi. Postgrad Med., 46; 209 (1969).
86.
MayerG. G., ChaseT., FarvarB., WardM. A., LongO. F., KovipF., ZinsserH. H.: Metabolic studies on the formation of calcium oxalate stones with special enphasis on vit. B6 and uric and metabolism. Bull. N.Y. Acad. Med., 44; 28 (1968).
MaxfieldM.: Molecular form of human urinary mucoprotein present under physiological conditions. Bioch. Biophys Acta, 49; 548 (1961).
89.
McKenzieJ. K., McQueenE. G.: Immunofluorescent localization of Tam-Horsfall mucoprotein in human kidney. J. Clin. Path., 22; 334 (1969).
90.
MelickR. A., HennemanP. H.: Clinical and laboratory studies of 207 consecutive patients in a kidney-stone clinic. N. England J. Med., 259; 307 (1958)
91.
MeyerovitchA.: Étiologie des lithiases. Lithiases d'organisme et lithiases d'organe. Rev. Prat., 18; 3243 (1968).
92.
MioniG., HuberW., BozzatoG., D'AngeloA., OrsiF., BertagliaE., MaschioG.: Effetti della ipercalcemia acuta sulla clearance renale del calcio e del fosforo nell'uremia cronica. Minerva Nefrol., 17; 75 (1970).
93.
MilliezP., LagrueG., LaudatM. H., MayerPh., MonoylivitchP.: L'acide glycuronique au cours des lithiases rénales calciques. Path. Biol., 8; 1855 (1960).
94.
ModlinM.: Letters to the editor. Lancet, 11; 734 (1968).
95.
ModlinM.: The aetiology of renal stones: a new concept arising from studies on a stone free population. Ann. Roy. Coll. Surg. Engl., 40; 155 (1967).
96.
ModlinM.: Renal calculus in the republic of South Africa. in: Renal Stones Research Symposium, pag. 209. J. & A. Churchill Ltd., London1969.
97.
MooreC. A., BunceG. E.: Reduction in frequency of renal calculus formation by oral magnesium administration. Invest. Urol., 2; 7 (1964).
98.
Mongiorgi: Comunicazione personale
99.
NordinB. E. C., SmithD. A.: Diagnostic procedure in disorders of calcium metabolism.Churchill Ed., London1965.
100.
NordinB. E. C., RobertsonW. G.: Calcium phosphate and oxalate ion-products in normal and stone-forming urines. Brit. Med. J., 1; 450 (1966).
101.
NordinB. E. C.: Calcium stones in kidney. Brit. Med. J., 2; 711 (1968.
102.
OreopulosD. G., SoyannwoM. A. O., McGeownM. G.: Magnesium/calcium ratio in urine of patients with renal stones. Lancet, 11; 420 (1968).
103.
OreopulosD. G., SoyannwoM. A. O., McGeownM. G.: Magnesium excretion after calcium infusion and the significance of the Mg/Ca ratio in patients with renal stones. in: Renal Stone Rerearch Symposium, pag. 263. J. & A. Churchill Ltd., London1969.
104.
PakC. Y. C.: Physicochemical basis for formation of renal stones of calcium. Phosphate origin: calculation of the degree of saturation of urine with respect to brushite. J. Clin. Invest, 48; 1914 (1969).
105.
PakC. Y. C., RuskinB.: Calcification of collagen by urine in vitro: dependence on the degree of saturation of urine with respect to brushite. J. Clin. Invest, 49; 2353 (1970).
106.
PakC. Y. C., CoxJ. W., PowellE., BartterF. C.: Effect of the oral administration of ammonium chloride, sodium phosphate cellulose phosphate and parathyroid extract on the activity product of brushite in urine. Am. J. Med, 50; 67 (1961).
107.
PapadimitriouM., VickersJ., RamM. D.: Urinary excretion of calcium and other electrolytes in renal lithiasis. Lancet, 11; 1002 (1968).
108.
PeacockM., KnowlesF., NordinB. E. C.: Effect of calcium administration and deprivation on serum and urine calcium in stone-forming and control subject. Brit. Med. J., 1; 729 (1968).
109.
PeacockM., NordinB. E. C.: Tubular reabsorption of calcium in normal and hypercalcemics subjects. J. Clin. Path, 21; 353 (1968).
110.
PeacockM., NordinB. E. C.: The hypercalciuria of renal stone disease. in: Renal Stone Research Symposium, pag. 253. J. & A. Churchill Ltd, London1969.
PrienE. L., PrienE. L.Jr.: Composition and structure of urinary stone. Amer. J. Med, 45; 654 (1968).
113.
PronoseP., BartterF. C.: Diagnosis of hyperparathyroidism. Metabolism, 10; 349 (1961).
114.
RapoportA., CrasswellerP. O., HusdanH., FranG. L. A., ZweigM., JohnsonM. D.: The renal excretion of hydrogen-ion in uric acid stone formers. Metabolism, 16; 176 (1967).
115.
ResnickM., PridgenD. B., GoodmanH. O.: Genetic predisposition to formation of calcium oxalate renal calculi. N. Engl. J. Med, 278; 1313 (1968). — Renal Stone Research Symposium. J. & A. Churchill Ltd, London 1969.
116.
RobertsonW. G., PeacockM., NordinB. E. C.: Calcium crystalluria in recurrent renal stone formers. Lancet, 1; 21 (1969).
117.
RobertsonW. G., NordinB. E. C.: Activity products in urine. in: Renal Stone Research Symposium, pag. 221. J. & A. Churchill Ltd, London1969.
118.
RokkonesT., SkandsenS.: Mineralogical and clinical investigation of stones from the urinary tract. Acta Med. Scand, 187; 83 (1970).
119.
RusselR. G. G., Fleisch: Pyrophosphate and stone formation. in: Renal Stone Research Symposium, pag. 165. J. & A. Churchill Ltd, London1969.
120.
RusselR. G. G., WadstromL. B., LindstedtS., CareA. P., BisazS., FleischH.: The origin of iorganic pyrophosphate in urine. Clin. Sci, 37; 419 (1969).
121.
RusselR. G. G., HodgkinsonA.: The urinary excretion of inorganic pyrophosphate in hyperparathyroidism, hyperthyroidism, paget's disease and other disorders in bone metabolism. Clin. Sci, 36; 435 (1969).
122.
RusselR. G. G., HodgkinsonA.: The urinary excretion of inorganic pyrophosphate by normal subjects and patients with renal calculus. Clin. Sci, 31; 51 (1966).
123.
SamiyA. H. E., BrownJ. L., GlobusD. L., KesslerR. H., ThompsonD. D.: Interrelation between renal transport systems of magnesium and calcium. Amer. J. Physiol, 198; 599 (1960).
124.
SasdelliM., MorselliV., FabbriL.: Il moxicoumone in nefrologia. Atti della Tavola Rotonda sulla terapia vasoattiva, Malta 18–20 dicembre 1970.
ScottJ. T., DixonA. St. J., BynatersE. G. L.: Association of hyperuricaemia and gout with hyperparathyroidism. Brit. Med. J., 1; 1070 (1964).
127.
SmithM. Y. S., DentL. D., KingJ. S., BoyceW. H.: Uricemia and urolithiasis. J. Urol., 101; 637 (1969).
128.
SmithL. H., McCallJ. T.: Chemical nature of peptide inhibitors isolated from urine. in: Renal Stone Research Symposium, pag. 153. J. & A. Churchill Ltd., London1969.
129.
SmithL. H.Jr., HockadayT. D. R., EfronM. L., ClaytonJ. E.: Metebolic defect of primary hyperoxaluria. Trans. Ass. Amer. Physis., 77; 317 (1964).
130.
SolomonsC C., GoodmanS. L., RaleyC. M.: Use of calcium carbamide in the treatment of primary hyperoxaluria. New Engl. J. Med., 276; 207 (1967).
131.
SperlingO., De VriesA., KedemO.: Studies on the etiology of uric acid lithiasis. IV. Urinary non dialyzable substances in idiopathic uric acid lithiasis. J. Urol., 94; 286 (1965).
132.
StampT. B. C., StaceyT. E.: Evaluation of theorical renal phosphorus Threshold as on index of renal phosphorus handling. Clin. Sci., 39; 505 (1970)
133.
SutorJ.: Grouth studies of calcium oxalate in the presence of various ions and compounds. Brit. J. Urol, 16; 171 (1969).
134.
SutorD. J., WooleyS. E.: Composition of urinary calculi by X-ray diffraction. Collected data from various localities. Brit. J. Urol, 42; 302 (1970).
135.
SutorD. J.: Difficulties in the identification of mixed urinary calculi using the X-ray powder method. Brit. J. Urol, 40; 29 (1968).
136.
SutorD. J., ScheidtS.: Identification standars for human urinary calculus components, using crystallographic methods. Brit. J. Urol, 40; 22 (1968).
137.
SuttonR. A. L., WatsonL.: Urinary excretion of calcium and magnesium in primary hyperparathyroidism. Lancet, 1; 1000 (1969).
138.
TakasakiE., ShimotoE.: The urinary excretion of xalic acid and magnesium in oxalate urolithiasis. Invest. Urol, 5; 303 (1967).
139.
TakasakiE.: The urinary excretion of oxalic acid in vitamine B1 deficient rats. Invest. Urol, 7; 150 (1969).
140.
ThomasJ.: Caractères particuliers des lithiases selon leur nature chimique et indications thérapeutiques. Rev. Prat, 18; 3281 (1968).
141.
ThomasT., ThomasE., RabussierH., DesgrezP.: Ph, acidité titrrable et pouvoir-tampon urinaire dans la lithiase oxalique, la goutte et la lithiase urique. J. d'Urol, 74; 690 (1968).
142.
ThomasW. C.Jr.: Inhibitors of mineralization and renal stones. in: Renal Stone Research Symposium, pag. 141. J. & A. Churchill Ltd, London1969.
143.
TimmermanA., KollistratosG., FennerO., SommerE.: A tentative map suggesting the possible role of urinary minerals for the formation of renal stones. in: Renal Stone Research Symposium, pag. 273. J. & A. Churchill Ltd, London1969.
144.
TransbolJ., HalmemannS., HormunJ.: The tubular re-absorption of calcium in primary hyperparathyroidism and in non parathyroid hypercalcemia. Acta. Med. Scand, 184; 33 (1968).
145.
VerbanckM., KahnR. J.: Effects de l'intoxication a la vitamine D sur l'excretion renale d'acidité titable et d'ammoniaque. Acta Néphrol. Hôp. Necker, pag. 241 (1965).